Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

BEYONDSPRING INC.

(BYSI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Bio Therapeutic Drugs
07:42aRBC Raises Price Target on Regeneron Pharmaceuticals to $702 From $686, Maintains Secto..
MT
07:42aRBC Lifts Price Target on Vertex Pharmaceuticals to $281 From $276, Maintains Sector Pe..
MT
10/05Insider Sell: Regeneron Pharmaceuticals
MT
10/05Insider Sell: Regeneron Pharmaceuticals
MT
10/05Japan's Health Ministry Recommends Pfizer/BioNTech COVID-19 Jab For Children Over Six M..
MT
10/03US Stocks Rally After ISM Manufacturing Data; Crude Oil Jumps
MT
10/03US Stocks Start New Quarter Higher as Government Bond Yields, Manufacturing Gauge Drop
MT
10/03Insider Sell: Regeneron Pharmaceuticals
MT
10/03US Stocks Advance Midday After ISM Manufacturing Data; Crude Oil Advances
MT
10/03Goldman Sachs Raises Regeneron Pharmaceuticals Price Target to $970 From $796, Maintain..
MT
10/03Oxford BioTherapeutics Ltd. Enters into Commercial License Agreement with Genmab
CI
10/03Regeneron Elects Craig B. Thompson to Board of Directors and Technology Committee of th..
CI
09/30Correction to Sanofi and Regeneron Pharmaceuticals Article on Sept. 28
DJ
09/30A Chinese mRNA COVID vaccine is approved for the first time - in Indonesia
RE
09/29Regeneron Pharmaceuticals' Dupixent Receives FDA Approval for Chronic Skin Disease
MT
09/28Sanofi-Regeneron's Dupixent Wins First-in-Class US FDA Nod for Chronic Skin Disorder
MT
09/28Indonesia approves first home-grown COVID vaccine for emergency use - media
RE
09/28Regeneron Pharmaceuticals, Inc. and Sanofi Announce Approval of Dupixent® by FDA as the..
CI
09/28Sanofi, Regeneron Say Dupixent Gets FDA Approval to Treat Prurigo Nodularis Skin Diseas..
DJ
09/28Pfizer, BioNTech Seeks European Nod for COVID Vaccine Booster for Children 5 to 11
MT
09/28Pfizer, BioNTech File European Medicines Agency Application for Omicron Booster Dose fo..
MT
09/28MaxCyte Signs Platform License Agreement With Vertex to Back Gene-Editing Program
MT
09/28MaxCyte Secures Strategic Platform License Deal; London Stocks Jump 7%
MT
09/28Indonesia approves first home-grown COVID vaccine for emergency use - media
RE
09/28Drugmakers Siegfried, Novavax Extend Aseptic Fill-finish Deal for COVID-19 Jab Until 20..
MT
09/27US Stocks Hit Fresh 2022 Lows After Latest Economic Data
MT
09/27US Stocks End Mixed Tuesday After Hitting Fresh 2022 Lows
MT
09/27Equities Set New 2022 Lows as Consumer Confidence, New-Home Sales Beat Views
MT
09/27Midday Report: US Stocks Set New 2022 Lows as Consumer Confidence, New-Hom..
MT
09/27European ADRs Climb Higher in Tuesday Trading
MT
09/27Vertex, CRISPR Say FDA Grants Rolling Review to Exa-Cel to Treat Sickle Cell Disease, B..
MT
09/27Zai Lab Signs Exclusive Collaboration, License Agreement With Seagen to Develop, Commer..
MT
09/27BIONTECH : Berenberg remains its Buy rating
MD
09/27Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics Announce Global exa-cel Reg..
CI
09/26European ADRs Decline in Monday Trading
MT
09/26Sector Update: Health Care Stocks Mixed Premarket Monday
MT
09/26Pfizer, BioNTech Seek FDA Approval for COVID-19 Vaccine Targeting Omicron Subvariants i..
MT
09/26Trending : Pfizer, BioNTech Seek OK for Covid-19 Booster in Kids
DJ
09/26Pfizer, BioNTech Submit US FDA Emergency Use Application For Omicron-Adapted Vaccine Fo..
MT
09/26Pfizer, BioNTech File FDA Application for Emergency Use Authorization of Omicron-Specif..
MT
09/26Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of O..
CI
09/26Pfizer, BioNTech Ask FDA to Approve Booster for Children
DJ
09/22BioNTech-Pfizer Seeks Swissmedic OK for Omicron Subvariant Vaccine
MT
09/20France clears Omicron-adapted COVID boosters for autumn vaccination drive
RE
09/20European ADRs Move Lower in Tuesday Trading
MT
09/20Decibel Therapeutics Files Investigational New Drug Application With US FDA for Product..
MT
09/19US Stocks Turn Higher as Investors Await Fed Rate Decision on Wednesday
MT
09/19US Stocks Turn Higher as Investors Await Fed Rate Decision on Wednesday; 2-Year Bond Yi..
MT
09/19Vaccine Makers Fall After Biden Says 'Pandemic is Over'
MT
09/19European ADRs Move Lower in Monday Trading
MT
09/19Agios Pharmaceuticals' CFO Resigns, Replacement Named
MT
09/19Pfizer Refuses Use of COVID-19 Vaccine in WHO Project to Boost mRNA Access
MT
09/16Pfizer, BioNTech Say EMA Committee Backs Change of COVID-19 Vaccine Conditional Approva..
MT
09/16Intellia Therapeutics, Regeneron Say Genome Editing Therapy Reduced Protein Concentrati..
MT
09/16Sector Update: Health Care Stocks Mixed Premarket Friday
MT
09/16Intellia Therapeutics, Regeneron Therapeutics Deliver Positive Early-Stage Data on ATTR..
MT
09/16Pfizer, BioNTech Receive European Medicines Agency Panel's Backing for Full Marketing P..
MT
09/16Canaccord Genuity Adjusts Price Target on Regeneron Pharmaceuticals to $750 From $700, ..
MT
09/16Pfizer Inc. and BioNTech SE Receive Positive Chmp Opinion for Conversion of Comirnaty® ..
CI
09/16Intellia and Regeneron Announce Initial Data from the Cardiomyopathy Arm of Ongoing Pha..
CI
09/16Regeneron Pharmaceuticals, Sanofi Say Atopic Dermatitis Drug Improved Skin Clearance in..
MT
09/15WHO Revokes Recommendations for COVID-19 Drugs from GSK, Roche-Regeneron
MT
09/15Regeneron Pharmaceuticals, Inc. Announces Positive Dupixent® Phase 3 Data in Children A..
CI
09/15Credit Suisse Raises Price Target on Genmab to DKK2,800 From DKK2,600, Citing Higher Da..
MT
09/15Alnylam, Regeneron Say Safety Data From Phase 1 Trial Support Continued Liver Disease D..
MT
09/15Alnylam and Regeneron Report Promising Data from Ongoing Phase 1 Study of ALN-HSD in NA..
CI
09/15Alnylam Pharmaceuticals, Inc. and Regeneron Pharmaceuticals Announces Preliminary Phase..
CI
09/15Regeneron, Alnylam to Advance NASH Candidate Into Phase 2
DJ
09/14Pfizer's African Partner Biovac Starts Production of COVID-19 Jabs to Meet 100 Million ..
MT
09/14Pfizer starts late-stage trial of mRNA-based flu vaccine
RE
09/14Moderna open to supplying COVID vaccines to China, CEO says
RE
09/13Insider Sell: Regeneron Pharmaceuticals
MT
09/13Transcript : Genmab A/S Presents at Morgan Stanley 20th Annual Global Healthc..
CI
09/13Piper Sandler Raises Price Target on Regeneron Pharmaceuticals to $775 From $692, Maint..
MT
09/12Wuxi Biologics, Peers Slump After Biden Signs Order to Boost U.S. Biotech Industry
DJ
09/12Insider Sell: Regeneron Pharmaceuticals
MT
09/12EU Drug Regulator Panel Backs Pfizer, BioNTech Booster Dose of Omicron COVID-19 Vaccine
MT
09/12Pfizer, BioNTech Get Positive CHMP Opinion for Covid-19 Vaccine Booster in EU
DJ
09/12European Medicines Agency Panel Backs Pfizer-BioNTech's Modified COVID-19 Vaccine Boost..
MT
09/12Guggenheim Adjusts Regeneron Pharmaceuticals Price Target to $925 From $740, Maintains ..
MT
09/12EU regulator backs Pfizer/BioNTech BA.4/5-adapted COVID booster
RE
09/12Pfizer and BioNTech SE Receive Positive CHMP Opinion for Omicron Ba.4/Ba.5-Adapted Biva..
CI
09/12Transcript : Regeneron Pharmaceuticals, Inc. Presents at Morgan Stanley 20th ..
CI
09/12Wells Fargo Adjusts Regeneron Pharmaceuticals' Price Target to $800 from $735, Maintain..
MT
09/12Transcript : Regeneron Pharmaceuticals, Inc. - Special Call
CI
09/12Regeneron Pharmaceuticals, Inc. Announces Positive Neoadjuvant Libtayo® Monotherapy Dat..
CI
09/12Regeneron Pharmaceuticals Says Combination Treatment Showed Higher Than 60% Response Ra..
MT
09/12Regeneron Pharmaceuticals, Inc. Announces the Presentation of Positive Data from Multip..
CI
09/10Novel Regeneron Bispecific Antibodies Show Encouraging Anti-tumor Activity in Two Advan..
CI
09/09Regeneron Pharmaceuticals Shares Rise After Analyst Upgrades, Price Target Raises
MT
09/09Pfizer, BioNTech's COVID-19 Vaccine Approved by Health Canada for Children Six Months t..
MT
09/09BioNTech Says Cancer Therapy Candidate Showed 'Encouraging Signs' of Anti-Tumor Activit..
MT
09/09Transcript : Vertex Pharmaceuticals Incorporated Presents at 2022 Wells Fargo..
CI
09/09BioNTech Cell Therapy Shows Signs of Anti-Tumor Activity in Early-Stage Study
MT
09/09Biontech Presents Encouraging Phase 1/2 Follow-Up Data for Car-T Candidate Bnt211 in Ha..
CI
09/09SVB Securities Adjusts Price Target on Regeneron Pharmaceuticals to $756 From $630, Mai..
MT
09/09Barclays Adjusts Regeneron Pharmaceuticals' Price Target to $815 From $735, Maintains O..
MT
09/09Morgan Stanley Upgrades Regeneron Pharmaceuticals to Overweight From Equalweight, Boost..
MT
09/09Jefferies Upgrades Regeneron Pharmaceuticals to Hold From Underperform, Raises Price Ta..
MT
09/09Analyst recommendations: American Water, Darktrace, Nasdaq, Rege..
MS
Upcoming event on BEYONDSPRING INC.